Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Cancer Causes Control. 1995 May;6(3):235-9.

PMID:
7612803
[PubMed - indexed for MEDLINE]
2.

Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis.

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Am J Epidemiol. 1995 Sep 15;142(6):608-11.

PMID:
7653469
[PubMed - indexed for MEDLINE]
3.

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

PMID:
8850273
[PubMed - indexed for MEDLINE]
Free Article
4.

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90.

PMID:
9610787
[PubMed - indexed for MEDLINE]
Free Article
5.

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467-72.

PMID:
8220092
[PubMed - indexed for MEDLINE]
Free Article
6.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.

PMID:
16103450
[PubMed - indexed for MEDLINE]
Free Article
7.

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF.

Cancer Causes Control. 1998 Aug;9(4):425-32.

PMID:
9794175
[PubMed - indexed for MEDLINE]
8.

Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer.

Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ.

Am J Epidemiol. 2003 Feb 15;157(4):335-44. Erratum in: Am J Epidemiol. 2003 Jun 15;157(12):1126.

PMID:
12578804
[PubMed - indexed for MEDLINE]
Free Article
9.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

PMID:
17301263
[PubMed - indexed for MEDLINE]
Free Article
10.

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D.

Cancer Causes Control. 1997 Jul;8(4):615-25.

PMID:
9242478
[PubMed - indexed for MEDLINE]
11.

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.

Barnett CM, Nielson CM, Shannon J, Chan JM, Shikany JM, Bauer DC, Hoffman AR, Barrett-Connor E, Orwoll E, Beer TM.

Cancer Causes Control. 2010 Aug;21(8):1297-303. doi: 10.1007/s10552-010-9557-y. Epub 2010 Apr 10.

PMID:
20383574
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.

Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P.

Int J Cancer. 2011 Mar 15;128(6):1414-24. doi: 10.1002/ijc.25439.

PMID:
20473927
[PubMed - indexed for MEDLINE]
13.

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

Jacobs ET, Giuliano AR, Martínez ME, Hollis BW, Reid ME, Marshall JR.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):533-7.

PMID:
15225833
[PubMed - indexed for MEDLINE]
14.

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).

Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P.

Cancer Causes Control. 2000 Oct;11(9):847-52.

PMID:
11075874
[PubMed - indexed for MEDLINE]
15.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

PMID:
10096552
[PubMed - indexed for MEDLINE]
Free Article
16.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720
[PubMed - indexed for MEDLINE]
17.

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52.

PMID:
15066918
[PubMed - indexed for MEDLINE]
Free Article
18.

Association of prostate cancer with vitamin D receptor gene polymorphism.

Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA.

Cancer Res. 1996 Sep 15;56(18):4108-10.

PMID:
8797574
[PubMed - indexed for MEDLINE]
Free Article
19.

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M.

Int J Cancer. 2004 Jan 1;108(1):104-8.

PMID:
14618623
[PubMed - indexed for MEDLINE]
20.

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):967-9.

PMID:
9367072
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk